Find your next M&A target

The Israeli medical company has developed a surface cryotherapy equipment and system, which can be inserted into the bladder through a cystoscope (endoscope) to visualize the interior of the bladder. Surface cryotherapy is a potential paradigm shift in the treatment of superficial bladder cancer. The reaction of the tissue to the frozen spray can be seen in real-time so that the therapist can assess the destruction of the tissue in real-time and has excellent visualization in all operative stages. The project adopted a new method for treating superficial bladder cancer. It uses surface cryotherapy, which uses extreme cold to freeze and destroy abnormal tissues. Its minimally invasive solution for non-muscle invasive bladder cancer (NMIBC) provides outpatient treatment options for surgery. The company announced that their cryoablation for bladder cancer has made a successful preclinical trial. The company seeks investment for next coming steps.